<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NPG//DTD XML Article//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName NPG_XML_Article.dtd?><?SourceDTD.Version 2.7.10?><?ConverterInfo.XSLTName nature2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4812247</article-id><article-id pub-id-type="pii">srep23530</article-id><article-id pub-id-type="doi">10.1038/srep23530</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Osinalde</surname><given-names>Nerea</given-names></name><xref ref-type="aff" rid="a1">1</xref><xref ref-type="author-notes" rid="n1">*</xref></contrib><contrib contrib-type="author"><name><surname>Sánchez-Quiles</surname><given-names>Virginia</given-names></name><xref ref-type="aff" rid="a1">1</xref><xref ref-type="author-notes" rid="n2">†</xref></contrib><contrib contrib-type="author"><name><surname>Blagoev</surname><given-names>Blagoy</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kratchmarova</surname><given-names>Irina</given-names></name><xref ref-type="corresp" rid="c1">a</xref><xref ref-type="aff" rid="a1">1</xref></contrib><aff id="a1"><label>1</label><institution>Department of Biochemistry and Molecular Biology, University of Southern Denmark</institution>, 5230 Odense M, <country>Denmark</country></aff></contrib-group><author-notes><corresp id="c1"><label>a</label><email>ihk@bmb.sdu.dk</email></corresp><fn id="n1"><label>*</label><p><text><SENT sid="1" pm="."><plain>Present address: Department of Biochemistry and Molecular Biology, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain. </plain></SENT>
</text></p></fn><fn id="n2"><label>†</label><p><text><SENT sid="2" pm="."><plain>Present address: Molecular Oncology Group, UMR 144 CNRS, Curie Institute. </plain></SENT>
<SENT sid="3" pm="."><plain>26, rue d’Ulm. </plain></SENT>
<SENT sid="4" pm="."><plain>75248 Paris, France. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>03</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>6</volume><elocation-id>23530</elocation-id><history><date date-type="received"><day>15</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>08</day><month>03</month><year>2016</year></date></history><permissions><copyright-statement>Copyright © 2016, Macmillan Publishers Limited</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Macmillan Publishers Limited</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="5" pm="."><plain>Interleukin-2 (IL-2) stimulation results in T-cell growth as a consequence of activation of highly sophisticated and fine-tuned signaling pathways. </plain></SENT>
<SENT sid="6" pm="."><plain>Despite lacking intrinsic enzymatic activity, scaffold proteins such as Gab2, play a pivotal role in IL-2-triggered signal transduction integrating, diversifying and amplifying the signal by serving as a platform for the assembly of effectors proteins. </plain></SENT>
<SENT sid="7" pm="."><plain>Traditionally, Gab2-mediated protein recruitment was believed to solely depend on cytokine-induced phosphotyrosine moieties. </plain></SENT>
<SENT sid="8" pm="."><plain>At present, phosphorylation on serine/threonine residues is also emerging as a key mediator of Gab2-dependent signal regulation. </plain></SENT>
<SENT sid="9" pm="."><plain>Despite its relevance, IL-2-triggered regulation on Gab2 phosphorylation is yet poorly understood. </plain></SENT>
<SENT sid="10" pm="."><plain>Combining antibody- and TiO2-based enrichment of the scaffold protein with SILAC quantitative mass spectrometry we disclose the prominent regulation IL-2 exerts on Gab2 serine/threonine phosphorylation by showing that at least 18 serines and 1 threonine, including previously non-reported ones, become phosphorylated in response to cytokine stimulation. </plain></SENT>
<SENT sid="11" pm="."><plain>Additionally, we decipher the interactome of the docking protein in resting and cytokine-treated T-lymphocytes and besides well-known Gab2 interactors we discover three novel cytokine-inducible Gab2-binding proteins. </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, our data provide novel insights and a wealth of candidates for future studies that will shed light into the role of Gab2 in IL-2-initiated signal transduction. </plain></SENT>
</text></SecTag></p></abstract></article-meta></front><body><p><text><SENT sid="13" pm="."><plain>Interleukin 2 (IL-2) is a pleiotropic cytokine that promotes differentiation of naive CD4+ and CD8+ T-lymphocytes into effector and memory T-cells respectively, augments the cytolytic activity of CD8+ T-cells and natural killer cells (NK-cells), triggers activation-induced cell death (AICD) and stimulates proliferation of different immune cell types1234. </plain></SENT>
<SENT sid="14" pm="."><plain>Indeed, due to its capacity to promote T-cell growth, IL-2 has clinically emerged as the most widely used cytokine in adoptive immunotherapy for cancer56. </plain></SENT>
<SENT sid="15" pm="."><plain>Despite its effectiveness, IL-2 treatment is often accompanied by undesired side effects that must be overcome in order to ensure safer therapies. </plain></SENT>
<SENT sid="16" pm="."><plain>Hence, the characterization of the molecular events underlying IL-2-dependent responses constitutes a key way into the development of more accurate treatments. </plain></SENT>
</text></p><p><text><SENT sid="17" pm="."><plain>Binding of IL-2 to its transmembrane receptor (IL-2R) results in the rapid activation of highly interconnected and carefully orchestrated signaling pathways that ultimately converge into the nucleus eventually elaborating the desired cellular output78. </plain></SENT>
<SENT sid="18" pm="."><plain>The initial step in IL-2 signaling involves activation of JAK tyrosine kinases which phosphorylate the receptor, thus creating anchoring sites for signal relay molecules bearing phosphotyrosine-binding (PTB) and Src-homology 2 (SH2) domains that are subsequently phosphorylated as well910. </plain></SENT>
<SENT sid="19" pm="."><plain>Hence, the binding of the cytokine to the cell surface promotes the formation of large intracellular molecular complexes that allow a fast and amplified propagation of the signal. </plain></SENT>
<SENT sid="20" pm="."><plain>Among the recruited proteins, several of them constitute enzymes or transcription factors whose activity is indeed regulated by site-specific modifications1112. </plain></SENT>
<SENT sid="21" pm="."><plain>Additionally, some of the molecular characters associated to the activated receptors represent scaffold or docking proteins with no inherent enzymatic or transcriptional activity, but importantly serving as physical platforms facilitating the assembly of the signalling hubs. </plain></SENT>
<SENT sid="22" pm="."><plain>Scaffold molecules thereby enable the localization of other effector proteins at specific cellular compartments, protect them from inactivation and integrate positive and negative feedback mechanisms, ultimately allowing the modulation of the signal transduction13. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Among the scaffold proteins involved in the signaling transduction triggered by IL-2 stands the human Grb2-associate binder (Gab) family, which is comprised by three members (Gab1–3). </plain></SENT>
<SENT sid="24" pm="."><plain>Upon stimulation Gab proteins become phosphorylated and act as molecular bridges between growth factor- or cytokine-activated receptor complexes and downstream signaling molecules141516. </plain></SENT>
<SENT sid="25" pm="."><plain>In fact, among others we have demonstrated that docking proteins Gab2 and Gab3 become tyrosine phosphorylated and hence, participate in the signaling networks initiated by IL-2 in CD4+ T-lymphocytes1718192021. </plain></SENT>
<SENT sid="26" pm="."><plain>Upon stimulation, phosphotyrosine moieties mediate the interaction with diverse signaling molecules, such as, PTPN11, p85 regulatory subunit of PI-3 kinase, PLCγ, Shc and CrkL which leads to the activation of RAS/MAPK and PI3K/AKT signaling pathways22. </plain></SENT>
<SENT sid="27" pm="."><plain>Indeed, Gab2 overexpression has been shown to promote the alteration of these signaling branches, importantly contributing to the development of distinct cancers including breast and ovarian cancer, leukemia and melanoma232425. </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>At present, serine and threonine phosphorylations of Gabs are emerging as key regulatory mechanism that can determine the fate of the signal. </plain></SENT>
<SENT sid="29" pm="."><plain>Lynch and co-workers first demonstrated that AKT-mediated phosphorylation on Gab2 S159 contributes to the attenuation of heregulin (HRG)-activated signaling pathways by uncoupling Gab2 from ErbB receptors26. </plain></SENT>
<SENT sid="30" pm="."><plain>Similarly, growth factor-triggered phosphorylation on Gab2 S210 and T391 has been shown to mediate negative feedback regulation by recruiting 14–3–3 proteins that disrupt Gab2/Grb2 interaction27. </plain></SENT>
<SENT sid="31" pm="."><plain>The biological significance of such finding became clear with the recent discovery that Gab1 T387, corresponding to Gab2 T391, is mutated (T387N) in breast cancer which results in EGF-independent proliferation of mammary epithelial cells as a consequence of impaired signal attenuation mechanism28. </plain></SENT>
<SENT sid="32" pm="."><plain>Consequently, the biological relevance of Gab2 phosphorylation occurring not only on tyrosines but also on serine and threonine residues is indisputable. </plain></SENT>
</text></p><p><text><SENT sid="33" pm="."><plain>Biochemical analyses have already suggested that Gab2 is highly phosphorylated on serine and threonine residues in response to IL-217. </plain></SENT>
<SENT sid="34" pm="."><plain>However, the precise effect that IL-2 exerts on the distinct site-specific phosphorylable residues on the scaffold proteins remains elusive. </plain></SENT>
<SENT sid="35" pm="."><plain>Here, we present the largest phosphoproteomic study depicting Gab2 phosphorylations in resting and IL-2-treated CD4+ T-lymphocytes. </plain></SENT>
<SENT sid="36" pm="."><plain>We identify 29 distinct phosphorylations on human Gab2 including 3 novel phosphorylated serine residues (pS146, pS147 and pS459) that have never been reported before. </plain></SENT>
<SENT sid="37" pm="."><plain>More importantly, we provide robust quantification data regarding 24 phosphorylation sites and provide evidence indicating that IL-2 triggers at least the phosphorylation of 18 serines and 1 threonine. </plain></SENT>
<SENT sid="38" pm="."><plain>Additionally, considering that the role of Gab2 consists on serving as a molecular platform to recruit distinct signaling proteins, we dissected the Gab2 interactome in resting and cytokine-treated T-lymphocytes by taking advantage of Stable Isotope Labeling by Amino acids in Cell culture (SILAC) quantitative mass spectrometry (Q-MS)29303132. </plain></SENT>
<SENT sid="39" pm="."><plain>Besides detecting already reported cytokine-dependent and – independent Gab2 interactors, we discovered 3 previously unknown cytokine-inducible Gab2-binding proteins which were further validated by Western blotting. </plain></SENT>
<SENT sid="40" pm="."><plain>Collectively, the data provided here considerably expand the current knowledge of the IL-2-dependent regulation of Gab2 which may originate a plethora of future investigations shedding new light into the role of the scaffold proteins in the signaling networks initiated by IL-2. </plain></SENT>
</text></p><SecTag type="RESULTS"><sec disp-level="1"><title><text><SENT sid="41" pm="."><plain>Results </plain></SENT>
</text></title><sec disp-level="2"><title><text><SENT sid="42" pm="."><plain>Kit225 T-lymphocytes express Gab2 and Gab3 but not Gab1 </plain></SENT>
</text></title><p><text><SENT sid="43" pm="."><plain>Our previous studies deciphering the tyrosine-phosphoproteome of IL-2 pathways demonstrated that Gab2 and Gab3 participate in the signal transduction initiated by the cytokine in Kit225 T-lymphocytes2021. </plain></SENT>
<SENT sid="44" pm="."><plain>Gab1, in turn, has never been identified in those experiments, which does not necessarily imply that is not expressed in Kit225 T-cells. </plain></SENT>
<SENT sid="45" pm="."><plain>For that reason, in order to determine which Gab family members are expressed in this CD4+ T-cell line, mRNA levels of each gene-product were measured by real time quantitative PCR. </plain></SENT>
<SENT sid="46" pm="."><plain>As shown in Fig. 1A, mRNA levels of Gab2 and Gab3 were high in Kit225 T-cells, whereas Gab1 gene expression was nearly undetectable. </plain></SENT>
<SENT sid="47" pm="."><plain>On the contrary, HeLa cells expressed high levels of Gab1 but low or almost undetectable amounts of Gab2 and Gab3, which is in agreement with recently published data33. </plain></SENT>
<SENT sid="48" pm="."><plain>In line with that, Western blot analyses revealed that expression of Gab1 and Gab2 is restricted to HeLa and Kit225 T-cell, respectively (Fig. 1B). </plain></SENT>
<SENT sid="49" pm="."><plain>Antibody-based detection of Gab3 was not successful but our previous mass spectrometry-based works have repeatedly demonstrated that Gab3 is also expressed in Kit225 T-lymphocytes2021. </plain></SENT>
<SENT sid="50" pm="."><plain>Altogether, our data indicate that Gab2 and Gab3 are the only Gab family members predominantly expressed in Kit225 T-cells and hence, participating in IL-2 signal transduction. </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="51" pm="."><plain>SILAC-based quantitative phosphoproteomics/proteomics approach to characterize IL-2-triggered regulation of Gab2 </plain></SENT>
</text></title><p><text><SENT sid="52" pm="."><plain>Gab2 and Gab3 family members share moderate sequence homology (33.4% identity) but they conserve the same modular structure16 (Supplementary Fig. </plain></SENT>
<SENT sid="53" pm="."><plain>S1). </plain></SENT>
<SENT sid="54" pm="."><plain>Therefore, it seems plausible that IL-2-triggered regulation of both scaffold proteins does not differ so much. </plain></SENT>
<SENT sid="55" pm="."><plain>Nonetheless, Gab2 is larger than Gab3 and contains more protein binding regions which may explain why Gab2-deficient mice show more defects that Gab3-deficient ones343536. </plain></SENT>
<SENT sid="56" pm="."><plain>For that reason, we decided to focus our investigation on studying in detail IL-2-mediated modulation of Gab2 as the representative Gab family member expressed in Kit225 T-cells. </plain></SENT>
</text></p><p><text><SENT sid="57" pm="."><plain>To depict Gab2 site-specific phosphorylation events and unveil the cytokine-dependent and –independent interactors of the scaffold protein we followed the experimental design outlined in Fig. 2A. </plain></SENT>
<SENT sid="58" pm="."><plain>Two populations of Kit225 T-cells were cultured in “light” or “heavy” media and were kept unstimulated (Ctr) or were stimulated for 5 minutes with IL-2, respectively. </plain></SENT>
<SENT sid="59" pm="."><plain>After cell lysis, samples were equally mixed, subjected to immunoprecipitation using an antibody against Gab2 and eluted immune complexes were fractionated by SDS-PAGE followed by in-gel digestion. </plain></SENT>
<SENT sid="60" pm="."><plain>Part of the sample was desalted and directly analyzed by LC-MS/MS aiming to detect Gab2-interacting partners whereas the remaining part was enriched in phosphopeptides using TiO2 beads prior to MS analysis. </plain></SENT>
<SENT sid="61" pm="."><plain>In addition to detect site-specific phosphorylations and putative Gab2 interactors, the use of SILAC allows discerning between IL-2-dependent and -independent phosphorylation events as well as constitutive and IL-2-inducible Gab2 interactors. </plain></SENT>
<SENT sid="62" pm="."><plain>A phosphopeptide bearing a site-specific phosphorylation that is not affected by IL-2 stimulation will be similarly enriched in resting and cytokine-treated cells, thus it will display a SILAC IL-2/Ctr ratio of 1 (Fig. 2B, left MS spectra). </plain></SENT>
<SENT sid="63" pm="."><plain>Likewise, peptides derived from a protein that is constitutively associated with the scaffold protein will also show a SILAC ratio of 1. </plain></SENT>
<SENT sid="64" pm="."><plain>On the contrary, if IL-2 induces phosphorylation on a specific residue or promotes an interaction between Gab2 and a signaling protein, the corresponding phosphopeptide and peptides respectively, will be more abundant in the cytokine-treated condition (Fig. 2B, right MS spectra). </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="65" pm="."><plain>Depicting Gab2 phosphorylation in resting and IL-2-treated T-lymphocytes </plain></SENT>
</text></title><p><text><SENT sid="66" pm="."><plain>Following the approach described above, we confidently identified 29 amino acids on Gab2 that are phosphorylated in vivo including 22 phosphorylated serines (pS), 5 phosphorylated threonines (pT) and 2 phosphorylated tyrosines (pY). </plain></SENT>
<SENT sid="67" pm="."><plain>Interestingly, 6 of these Gab2 pS (pS133, pS148, pS149, pS223, pS281, pS422) are conserved in the Gab family member Gab3 (corresponding to pS132, pS141, pS142, pS209, pS242, pS362, respectively) that is also expressed in Kit225 T-lymphocytes (Table 1). </plain></SENT>
<SENT sid="68" pm="."><plain>In addition, the phosphorylated Gab2 residues S141, T319 and T391 align with distinct but still phosphorylable Gab3 residues (T134, S273 and S344, respectively). </plain></SENT>
<SENT sid="69" pm="."><plain>In fact, we have already demonstrated that Gab3 S344 and S362 are phosphorylated in IL-2-treated CD4+ T-lymphocytes20. </plain></SENT>
<SENT sid="70" pm="."><plain>Altogether, it seems plausible that the putative and confirmed Gab3 phosphosites mentioned above are subjected to similar regulation as Gab2 in Kit225 T-cells upon cytokine treatment. </plain></SENT>
</text></p><p><text><SENT sid="71" pm="."><plain>It is worth highlighting that this is the first study demonstrating that Gab2 S147 and S459 can be phosphorylated in human CD4+ T-lymphocytes. </plain></SENT>
<SENT sid="72" pm="."><plain>Moreover, this study provides unprecedented evidence indicating that human Gab2 S146 can also be phosphorylated, a residue that was already reported to be modified in mice37. </plain></SENT>
<SENT sid="73" pm="."><plain>The precise assignment of those phosphorylation sites was verified by manual annotation of their corresponding fragmentation spectra. </plain></SENT>
<SENT sid="74" pm="."><plain>As shown in Fig. 3A, the presence of the 984.58+1 ion (y9** in SpSPAELpS146SpSSQHLLR) and the absence of the 1093.4534+1 ion (y8 in SpSPAELSpS147pSSQHLLR) supports the unambiguous identification of the phosphorylation of S146 residue in Gab2. </plain></SENT>
<SENT sid="75" pm="."><plain>Similarly, the presence of the 915.51+1 and 846.488+1 ions (y8* and y7 in SpSPAELSpS147SSQHLLR) and the absence of the ion 915.51+1 (y7 in SpSPAELSSpS148SQHLLR or SpSPAELSSSpS149QHLLR) allows to assign the position of the phosphosite to S147 of Gab2 (Fig. 3B). </plain></SENT>
<SENT sid="76" pm="."><plain>Regarding the Gab2 phosphopeptide comprising amino acid residues 443–467, the discriminating ions y8 and y9* indicate that among the six phosphorylable residues within the Gab2 phosphopeptide 443–467, only S459 is phosphorylated (Fig. 3C). </plain></SENT>
</text></p><p><text><SENT sid="77" pm="."><plain>Gab2 is known to be tyrosine phosphorylated in response to IL-2 and accordingly we found that Y476 and Y643 become phosphorylated in cytokine-treated CD4+ T-lymphocytes (Supplementary Fig. </plain></SENT>
<SENT sid="78" pm="."><plain>S2). </plain></SENT>
<SENT sid="79" pm="."><plain>More interestingly, the study presented here identified a large number of Gab2 pS/pT residues that are differentially regulated in response to IL-2 stimulation (Table 1). </plain></SENT>
<SENT sid="80" pm="."><plain>Our SILAC-based quantitative phosphoproteomic screen shows that phosphorylations on Gab2 S210, T287, T385 and T391 are not affected (0.5 &lt; IL-2/Ctr ratio &lt; 2, in both replicas) by cytokine stimulation. </plain></SENT>
<SENT sid="81" pm="."><plain>On the contrary, we provide evidence indicating that 18 serines and 1 threonine (T319) distributed along the central 400 amino acid-region of Gab2 (aa 141–543) become phosphorylated in vivo in CD4+ T-lymphocytes treated with IL-2. </plain></SENT>
<SENT sid="82" pm="."><plain>It should be noted that Gab2 pS147, pS149 and pS281 do not display a SILAC ratio in both replicas but still according to peak intensity data collected, the three phosphosites are induced in response to IL-2 treatment. </plain></SENT>
<SENT sid="83" pm="."><plain>As shown in Fig. 4, the three phosphosites are barely detectable in the light-labeled peak of the SILAC pair corresponding to resting T-cells (no intensity value). </plain></SENT>
<SENT sid="84" pm="."><plain>On the contrary, all of them were detected in the heavy-labeled SILAC condition corresponding to cytokine-treated T-lymphocytes and thus display a signal intensity which indicates that the three residues are phosphorylated upon IL-2 stimulation (Fig. 4A–C). </plain></SENT>
</text></p><p><text><SENT sid="85" pm="."><plain>Overall, results presented here represent the largest dataset of IL-2-dependent and-independent Gab2 phosphorylations reported to date. </plain></SENT>
<SENT sid="86" pm="."><plain>Hence, our study adds to a growing body of literature that points towards phosphorylations occurring on serine and threonine residues as key players in the signaling pathways modulated by Gab2. </plain></SENT>
<SENT sid="87" pm="."><plain>Future investigation will be necessary to clarify the role of each site-specific phosphorylation in the signal transduction initiated by IL-2. </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="88" pm="."><plain>Dissecting the interactome of Gab2 in IL-2-treated T-lymphocytes </plain></SENT>
</text></title><p><text><SENT sid="89" pm="."><plain>Phosphorylations on Gab2 serve as docking sites for downstream molecules that participate in the distinct signaling branches activated upon engagement of IL-2 and IL-2 receptor. </plain></SENT>
<SENT sid="90" pm="."><plain>In order to identify the proteins that are recruited to Gab2 in response to IL-2 stimulation, we combined immunoprecipitation of the endogenous scaffold protein with SILAC-based quantitative mass spectrometry as illustrated in Fig. 2A. </plain></SENT>
</text></p><p><text><SENT sid="91" pm="."><plain>We quantified 709 and 714 proteins in the first and second replica performed respectively, of which 646 were commonly quantified in the two experiments (Fig. 5A &amp; Supplementary Table S2). </plain></SENT>
<SENT sid="92" pm="."><plain>Comparison of the SILAC ratios obtained for those proteins showed strong correlation between the two biological replicas with Pearson coefficient of 0.9 (Fig. 5B). </plain></SENT>
<SENT sid="93" pm="."><plain>The majority of the proteins were found equally enriched in resting and IL-2-treated T-lymphocytes. </plain></SENT>
<SENT sid="94" pm="."><plain>These dataset embrace constitutive Gab2-binding proteins as well as unspecific interactors (Fig. 5C). </plain></SENT>
<SENT sid="95" pm="."><plain>It should be noted that among IL-2-independent Gab2-interacting proteins we detected the adaptor protein Grb2 (Supplementary Table S2). </plain></SENT>
<SENT sid="96" pm="."><plain>The constitutive association between the two proteins was further validated by Gab2 immunoprecipitation followed by Western blotting (Supplementary Fig. </plain></SENT>
<SENT sid="97" pm="."><plain>S3). </plain></SENT>
<SENT sid="98" pm="."><plain>These results indicate that the scaffold protein Gab2 and the adaptor protein Grb2 form a stable complex in CD4+ T-lymphocytes, which is line with previously published data38. </plain></SENT>
</text></p><p><text><SENT sid="99" pm="."><plain>More interestingly, our interactome analysis revealed 9 proteins that were significantly enriched in Gab2-containing immune complexes upon cytokine stimulation (IL-2/Ctr &gt;1.5; Significance B p-value &lt; 0.0001) indicating that their association with Gab2 depends on IL-2 treatment (Fig. 5C &amp; Supplementary Table S2). </plain></SENT>
<SENT sid="100" pm="."><plain>The 9 inducible Gab2-interacting proteins detected displayed consistent SILAC ratio in the two biological replicas performed (Fig. 6A). </plain></SENT>
<SENT sid="101" pm="."><plain>Tyrosine phosphatase PTPN11 and p85 PI3-kinase regulatory subunits alpha and beta (PIK3R1 and PIK3R2, respectively) were the IL-2-inducible Gab2 interactors showing the highest SILAC ratio. </plain></SENT>
<SENT sid="102" pm="."><plain>We validated these results by Western blot analyses which agree with previous studies showing that PTPN11 and p85 PI3-kinase interact with the tyrosine phosphorylated version of Gab2394041. </plain></SENT>
<SENT sid="103" pm="."><plain>Additionally, all catalytic subunits comprising the Class IA of PI3K family were also found to be enriched in IL-2 treated conditions (PIK3CA, PIK3CB and PIK3CD). </plain></SENT>
<SENT sid="104" pm="."><plain>More interestingly, for the first time this study provides evidence that DLAT (a subunit of the pyruvate dehydrogenase complex) and transcription factors ARID3A and ARID3B associate with Gab2 in response to IL-2 stimulation. </plain></SENT>
<SENT sid="105" pm="."><plain>We could further confirm by immunoblotting that the three novel Gab2 interactors discovered in this study, named DLAT, ARID3A and ARID3B, indeed interact with Gab2 scaffold protein in IL-2-stimulated Kit225 T-lymphocytes (Fig. 6B). </plain></SENT>
</text></p><p><text><SENT sid="106" pm="."><plain>The biological information extracted from the SILAC ratios obtained in the Gab2 immunoprecipitation experiments is unquestionable as they allow recognizing the specific cytokine-dependent interactors of the scaffold protein from a dataset composed by hundreds of proteins. </plain></SENT>
<SENT sid="107" pm="."><plain>Nonetheless, protein SILAC ratios do not provide information on the relative abundance of the proteins within the complex. </plain></SENT>
<SENT sid="108" pm="."><plain>This however can be extracted from the peptide intensity information in the dataset since it is assumed that the signal response of the three most abundant peptides can provide good approximation of the amount of protein42. </plain></SENT>
<SENT sid="109" pm="."><plain>Accordingly, we calculated the relative abundance of each IL-2-dependent Gab2 interactor detected in this study (Fig. 6C). </plain></SENT>
<SENT sid="110" pm="."><plain>Our data indicate that the most prominent proteins associating with Gab2 are PTPN11 and PIK3R1, indeed the two well-documented interactors of the scaffold protein. </plain></SENT>
<SENT sid="111" pm="."><plain>Strikingly, the binding level of ARID3B, the newly identified interactor of Gab2, was also found to be among the highest. </plain></SENT>
<SENT sid="112" pm="."><plain>The catalytic subunits of PI3-kinase family were detected lower in abundance as well as the novel interactors ARID3A and DLAT. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec disp-level="1"><title><text><SENT sid="113" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="114" pm="."><plain>IL-2-triggered signaling pathways are strictly fine-tuned by tyrosine phosphorylation events that trigger and modulate a wide range of processes such as protein-protein interaction, protein localization and enzymatic activity of distinct signaling molecules18192043. </plain></SENT>
<SENT sid="115" pm="."><plain>Initial events following cytokine and receptor engagement involve activation of JAK tyrosine kinases which in turn phosphorylate the receptor creating docking sites for signaling molecules that participate in transducing the signal initiated on the cell surface inside the cell. </plain></SENT>
<SENT sid="116" pm="."><plain>In response to cytokine stimulation, among others, Gab scaffold proteins are recruited to the activated receptor-complex where they become tyrosine phosphorylated and recruit additional effector molecules thereby integrating, amplifying and diversifying the signal transduction pathways4445. </plain></SENT>
</text></p><p><text><SENT sid="117" pm="."><plain>The initially discovered Gab family member Gab1 is believed to be ubiquitously expressed1546; however, here we demonstrate that Gab1 mRNA and protein levels are barely detectable in Kit225 T-cells. </plain></SENT>
<SENT sid="118" pm="."><plain>On the contrary, Gab2 and Gab3 are highly expressed in Kit225 CD4+ T-lymphocytes (Fig. 1). </plain></SENT>
<SENT sid="119" pm="."><plain>Indeed, we had previously demonstrated that Gab2 and Gab3 are tyrosine phosphorylated in response to IL-2 stimulation2021. </plain></SENT>
<SENT sid="120" pm="."><plain>Altogether, our studies provide evidence indicating that the latter two Gab family members are the only ones participating in the signal transduction initiated by IL-2 in Kit225 T-lymphocytes. </plain></SENT>
</text></p><p><text><SENT sid="121" pm="."><plain>Gab proteins can be recruited to the activated receptors through distinct mechanisms but according to the accumulated knowledge, the only mode for receptor interaction for Gab2 is indirectly via Grb216. </plain></SENT>
<SENT sid="122" pm="."><plain>Grb2 is a small adaptor protein composed by a Src homology 2 (SH2) domain that allows association with phosphorylated tyrosine resides, flanked by two SH3 domains that recognize proline-rich motifs47. </plain></SENT>
<SENT sid="123" pm="."><plain>Depending on the cellular system Grb2/Gab2 complex has been found to be either constitutive or inducible. </plain></SENT>
<SENT sid="124" pm="."><plain>Whereas IL-3 stimulation of the murine pro-B-cell line Ba/F3 results in a significantly enhanced interaction between Grb2 and Gab248, both proteins are identically associated in murine myeloid FDC-P1 cells treated or not with the colony-stimulating factor (M-CSF)49. </plain></SENT>
<SENT sid="125" pm="."><plain>We provide substantial evidence indicating that the adaptor protein Grb2 is constitutively associated with Gab2 in CD4+ Kit225 T-lymphocytes. </plain></SENT>
<SENT sid="126" pm="."><plain>Consequently, as the binding does not depend on tyrosine phosphorylation, it could be postulated that Grb2 SH3 domain and Gab2 proline-rich domains are involved in the formation of Grb2/Gab2 complex in Kit225 T-cells (Fig. 7). </plain></SENT>
<SENT sid="127" pm="."><plain>Noticeably, our previous study demonstrated that Grb2 can be recruited to cytokine-induced pY375 on IL-2Rγ (manuscript in preparation). </plain></SENT>
<SENT sid="128" pm="."><plain>Thus, it seem plausible that upon IL-2 stimulation Grb2 and its constitutive interactor Gab2 are recruited to the activated receptor complex through the SH2 domains of Grb2. </plain></SENT>
</text></p><p><text><SENT sid="129" pm="."><plain>It has been demonstrated that Grb2/Gab2 interaction can be disrupted as a consequence of Gab2 S210 and T391 phosphorylation and subsequent 14-3-3 protein recruitment27. </plain></SENT>
<SENT sid="130" pm="."><plain>We show that Gab2 pS210 and pT391 are not robustly induced in response to cytokine stimulation. </plain></SENT>
<SENT sid="131" pm="."><plain>In accordance, our Gab2 interactome study demonstrates that 14-3-3 beta/alpha, which displayed a SILAC ratio of 1.4 (Supplementary Table S2), is not recruited to Gab2 in IL-2-treated T-lymphocytes. </plain></SENT>
<SENT sid="132" pm="."><plain>Moreover, we observe that Grb2/Gab2 interaction remains unaffected upon cytokine stimulation (Fig. 7). </plain></SENT>
<SENT sid="133" pm="."><plain>Overall, the integration of the quantitative proteomics and phosphoproteomics analyses indicate that this negative feedback mechanism is still not activated in Kit225 T-lymphocytes treated with IL-2 for 5 minutes. </plain></SENT>
</text></p><p><text><SENT sid="134" pm="."><plain>Once assembled within the activated receptor complex, Gab2 is tyrosine phosphorylated in order to recruit downstream signaling molecules. </plain></SENT>
<SENT sid="135" pm="."><plain>Accordingly, our combinatorial Q-MS screen depicted several IL-2-triggered tyrosine phosphorylations in addition to numerous IL-2-inducible Gab2-interacting proteins. </plain></SENT>
<SENT sid="136" pm="."><plain>We demonstrate here that Gab2 Y476 and Y643 become phosphorylated in vivo upon 5 minutes treatment with IL-2 and provide substantial evidence indicating that the endogenous p85 regulatory subunit of PI3-kinase and tyrosine phosphatase PTPN11 associate with the scaffold protein in response to cytokine stimulation of T-lymphocytes. </plain></SENT>
<SENT sid="137" pm="."><plain>This is well in line with previous studies indicating that among others Gab2 pY476 and pY643 are involved in recruiting the p85 subunit of the PI3-kinase and the tyrosine phosphatase PTPN11, respectively3940. </plain></SENT>
<SENT sid="138" pm="."><plain>Additionally, it has been reported that Gab2 pS210 inhibits the recruitment of the tyrosine phosphatase PTPN11 in response to growth factors50. </plain></SENT>
<SENT sid="139" pm="."><plain>As mentioned above, our study unveiled that Gab2 pS210 is not subjected to IL-2-mediated regulation after 5 minutes stimulation with the cytokine. </plain></SENT>
<SENT sid="140" pm="."><plain>These data suggest that the mechanisms disrupting the interaction between Gab2 and PTPN11 are not activated at early stages of IL-2 signal transduction. </plain></SENT>
</text></p><p><text><SENT sid="141" pm="."><plain>Our investigation also resulted in the detection of three catalytic subunits of the Class IA PI3K family (PIK3CA, PIK3CB and PIK3CD) as cytokine-induced Gab2-binding proteins. </plain></SENT>
<SENT sid="142" pm="."><plain>In an attempt to determine whether they are direct or indirect interactors of the scaffold protein we calculated their relative abundance within the complex. </plain></SENT>
<SENT sid="143" pm="."><plain>In comparison to the well-known direct Gab2 interaction partners PTPN11 and p85 PI3-kinase that were found to be the most prominent interactors of the scaffold protein upon IL-2 stimulation, the relative abundance of the three catalytic PI3K subunits was very low. </plain></SENT>
<SENT sid="144" pm="."><plain>Hence, we postulate that whereas PTPN11 and p85 associate directly with tyrosine phosphorylated Gab2, the catalytic PI3K subunits detected in this study are recruited to the scaffold protein indirectly via the p85 regulatory subunit. </plain></SENT>
</text></p><p><text><SENT sid="145" pm="."><plain>The formation of Gab2/PTPN11 and Gab2/PI3K complexes leads to the activation of RAS/MAPK and PI3K/AKT signaling branches, respectively. </plain></SENT>
<SENT sid="146" pm="."><plain>Both pathways are essential to assure IL-2-induced proliferation of Kit225 T-lymphocytes as we demonstrated in our previous study20. </plain></SENT>
<SENT sid="147" pm="."><plain>MAPK and AKT serine/threonine kinases are the two core representatives of RAS/MAPK and PI3K/AKT pathways and both are known to phosphorylate a plethora of substrates. </plain></SENT>
<SENT sid="148" pm="."><plain>In addition to targeting downstream signaling molecules, both kinases also phosphorylate upstream effectors creating negative feedback mechanisms that are fundamental for the adequate orchestration of signal transduction. </plain></SENT>
<SENT sid="149" pm="."><plain>Arnaud and colleagues demonstrated that pre-treatment of T-cells with MEK and PI3K inhibitor decreased the characteristic shift of Gab2 in response to IL-2 suggesting that both signaling branches are involved in phosphorylating the scaffold protein Gab217. </plain></SENT>
<SENT sid="150" pm="."><plain>In fact, the study presented here uncovers the enormous impact IL-2 exerts on the serine/threonine phosphorylation status of Gab2. </plain></SENT>
<SENT sid="151" pm="."><plain>We found numerous site-specific Gab2 phosphorylations, including previously non-reported ones, that were induced in response to IL-2 stimulation in T-lymphocytes. </plain></SENT>
</text></p><p><text><SENT sid="152" pm="."><plain>Recently, Eulenfeld and co-workers have shown that MAPK-dependent phosphorylation on S551 in Gab1 is crucial for the recruitment of the scaffold protein to the plasma membrane and initiate a positive-feedback loop that results in enhanced MAPK activation51. </plain></SENT>
<SENT sid="153" pm="."><plain>This specific Gab1 residue is conserved in Gab2 and corresponds to S543. </plain></SENT>
<SENT sid="154" pm="."><plain>Strikingly, our SILAC-based quantitative phosphoproteomics screen shows that Gab2 pS543 is induced in vivo in Kit225 T-lymphocytes. </plain></SENT>
<SENT sid="155" pm="."><plain>Thus, it is likely that Gab2 pS543 is also involved in the membrane recruitment of Gab2 which allows the scaffold protein being in close proximity with signaling effectors that assure the propagation of signal transduction. </plain></SENT>
</text></p><p><text><SENT sid="156" pm="."><plain>More importantly, this study reveals large number of Gab2 serine/threonine phosphorylations, including three novel phosphorylated serines, that are modulated upon IL-2 stimulation of CD4+ T-lymphocytes (Fig. 7). </plain></SENT>
<SENT sid="157" pm="."><plain>In addition, we also discovered and further validated that DLAT, ARID3A and ARID3B associate with Gab2 in response to cytokine stimulation in Kit225 T-cells. </plain></SENT>
<SENT sid="158" pm="."><plain>The overall regulation of Gab2-mediated signal transduction is determined by the crosstalk of phosphosites that ultimately orchestrate the protein recruitment/release balance. </plain></SENT>
<SENT sid="159" pm="."><plain>Consequently, this study provides a wealth of candidates for future hypothesis-driven mechanism-focused studies that may gain insights into the regulation and role of Gab2 in the signal propagation initiated by IL-2. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec disp-level="1"><title><text><SENT sid="160" pm="."><plain>Methods </plain></SENT>
</text></title><sec disp-level="2"><title><text><SENT sid="161" pm="."><plain>Cell culture and stimulation </plain></SENT>
</text></title><p><text><SENT sid="162" pm="."><plain>The IL-2-dependent human T-cell line Kit22552 was maintained in RPMI 1640 medium supplemented with 10% FBS, 1% Glutamax, 1% penicillin/streptomycin, 1% sodium pyruvate and 16 U/ml of recombinant human IL-2 (kindly provided by AIDS Research and Reference Reagent Program, Division of AIDS, NIH, USA) at a density of 1 × 106 cells/ml at 37 °C and 5% CO2. </plain></SENT>
<SENT sid="163" pm="."><plain>For SILAC experiments the RPMI media was custom-made and deficient for L-Arg, and L-Lys (Gibco-Invitrogen). </plain></SENT>
<SENT sid="164" pm="."><plain>It was supplemented with glutamax, p/s and sodium pyruvate as mentioned before together with 10% dialyzed serum (Gibco-Invitrogen) and different versions of L-Lys (Lys0 or Lys4) and L-Arg (Arg0 or Arg6) from Cambridge Isotope Laboratories. </plain></SENT>
</text></p><p><text><SENT sid="165" pm="."><plain>Prior stimulation Kit225 T-cells were IL-2-deprived for 48 h to arrest them at the G1 phase of the cell cycle and resemble resting T-cells. </plain></SENT>
<SENT sid="166" pm="."><plain>IL-2-dependent signaling networks were induced by adding 200 U of IL-2 to 50.106 cells/ml and incubating for 5 min at 37 °C. </plain></SENT>
<SENT sid="167" pm="."><plain>In SILAC experiments, Kit225 T-cells grown in light media (Arg0/Lys0) were kept unstimulated and served as control whereas cells grown in heavy media (Arg6/Lys4) were stimulated with the cytokine as described above. </plain></SENT>
<SENT sid="168" pm="."><plain>Treatment was quenched by keeping cells on ice for 5 min and rapidly washing them repeatedly with chilled PBS prior proceeding with cell lysis. </plain></SENT>
</text></p><p><text><SENT sid="169" pm="."><plain>Human cervix epithelial adenocarcinoma HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Lonza) supplemented with 10% Fetal Bovine Serum, 1% Penicillin-Streptomycin and 1% L-Glutamine. </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="170" pm="."><plain>Protein extraction and immunoprecipitation </plain></SENT>
</text></title><p><text><SENT sid="171" pm="."><plain>Kit225 T-cells were lysed with ice-cold co-immunopreicpitation buffer (25 mM TrisHCl pH 7.5, 100 mM NaCl, 1% NP-40, 1 mM sodium pervanadate, 5 mM beta-glycerophosphate, 5 mM NaF, complete protease inhibitor cocktail (complete tablets, Roche)) and protein concentrations were estimated using BCA protein assay kit (Pierce). </plain></SENT>
</text></p><p><text><SENT sid="172" pm="."><plain>In SILAC experiments protein lysates corresponding to untreated and IL-2-stimulated cells were combined in 1:1 ratio according to their protein concentration whereas in non-SILAC experiments differentially treated cell conditions were processed separately. </plain></SENT>
<SENT sid="173" pm="."><plain>In both cases, cell lysates were pre-cleared for 1 h at 4 °C while magnetic beads coupled with protein G (ThermoFischer Scientific) were loaded with the antibody recognizing Gab2 by incubation at 4 °C. </plain></SENT>
<SENT sid="174" pm="."><plain>For immunoprecipitating Gab2 together with its corresponding binding partners, pre-cleared lysates were incubated with the magnetic beads coupled with the Gab2 antibody for 2 h at 4 °C in rotation. </plain></SENT>
<SENT sid="175" pm="."><plain>Then, immunoprecipitated proteins were washed 3 times with lysis buffer and eluted by 5 min boiling with loading buffer (50 mM Tris pH 6.8, 5% glycerol, 1.67% beta-mercaptoethanol, 1.67% SDS). </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="176" pm="."><plain>In-gel digestion and peptide extraction </plain></SENT>
</text></title><p><text><SENT sid="177" pm="."><plain>Eluted immunecomplexes were run in two parallel lanes of a precast NuPAGE 4–12% Bis-Tris Gel (Invitrogen) and visualized with Colloidal Blue (Invitrogen). </plain></SENT>
<SENT sid="178" pm="."><plain>Both gel lanes were separately cut into slices and subjected to in-gel trypsinization (Promega) as previously described53. </plain></SENT>
<SENT sid="179" pm="."><plain>Briefly, gel slices were subjected to reduction with 10 mM DTT, alkylation by 55 mM chloroacetamide and protein digestion by incubating with trypsin overnight at 37 °C. </plain></SENT>
</text></p><p><text><SENT sid="180" pm="."><plain>Resulting tryptic peptides were extracted from the gel by serial incubations with 100% ACN and 30% ACN/3% TFA. </plain></SENT>
<SENT sid="181" pm="."><plain>Finally, the solutions obtained in all the incubations were pooled together and dried down in a vacuum centrifuge. </plain></SENT>
<SENT sid="182" pm="."><plain>Whereas peptides derived from one of the lanes were directly concentrated and desalted using C18 stage tips (made in house using Empore disc –C18 Agilent Life Science) to further analyze by LC-MS/MS, peptides derived from the other lane were subjected to TiO2 enrichment prior to MS analysis. </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="183" pm="."><plain>Enrichment of phosphopeptides using TiO2 beads </plain></SENT>
</text></title><p><text><SENT sid="184" pm="."><plain>Enrichment of phosphopeptides was performed as previously described5354. </plain></SENT>
<SENT sid="185" pm="."><plain>5 mm diameter titansphere beads (GL Sciences) were mixed with the equilibration buffer (50 mg/ml DHB in 80%ACN/1%TFA) 1:1 ratio (w/w) and incubated for 30 min at room temperature whereas vacuum-dried samples were adjusted to 60% ACN/1% TFA. </plain></SENT>
<SENT sid="186" pm="."><plain>2 μl of equilibrated TiO2 slurry was added to the sample and incubated for 30 min at room temperature in with rotation for allowing phosphopeptides bind the beads. </plain></SENT>
<SENT sid="187" pm="."><plain>After brief centrifugation, supernatant was removed and TiO2 beads were transferred onto a home-made C8 Stage-Tip (Empore disc –C8 Agilent Life Science) where they were washed twice with 60% ACN/1% TFA. </plain></SENT>
<SENT sid="188" pm="."><plain>Phosphopeptides were eluted from the beads by two subsequent incubations using 5% NH4OH and 25% NH4OH/0.3% TFA. </plain></SENT>
<SENT sid="189" pm="."><plain>Finally, eluted phosphopeptides were dried down in a vacuum centrifuge and desalted using C18 stage tips prior LC-MS/MS analysis. </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="190" pm="."><plain>LC-MS/MS and data analysis </plain></SENT>
</text></title><p><text><SENT sid="191" pm="."><plain>LC-MS/MS analysis of was carried out using a reverse phase liquid chromatography system (EASY-nLC 1000 ultra-high pressure, Thermo Fisher Scientific) interfaced with a Q Exactive mass spectrometer (Thermo Fischer Scientific) via a nanoelectrospray source (Thermo Fisher Scientific). </plain></SENT>
<SENT sid="192" pm="."><plain>Acidified peptides were loaded on an analytical in-house packed column (20 cm × 75 μm, ReproSil-Pur C18-AQ 3 μm resin (Dr. Maisch GmbH)) in solvent A (0.5% acetic acid) and eluted by a nonlinear 120 min solvent B gradient (0.5% acetic acid, 80% ACN) at a flow rate of 250 nL/min. </plain></SENT>
<SENT sid="193" pm="."><plain>Q Exactive was operated in a top 10 data dependent mode. </plain></SENT>
<SENT sid="194" pm="."><plain>Survey scans were acquired at a resolution of 70,000 (m/z 400) and fragmentation spectra at 35,000 (m/z 400). </plain></SENT>
<SENT sid="195" pm="."><plain>Precursors were fragmented by higher energy C-trap dissociation (HCD) with normalized collision energy of 25 eV. </plain></SENT>
<SENT sid="196" pm="."><plain>The maximum injection time was 120 ms for survey and 124 ms for MS/MS scan. </plain></SENT>
<SENT sid="197" pm="."><plain>Repeat sequencing of peptide was minimized by excluding the selected peptide candidates for 45 s. </plain></SENT>
</text></p><p><text><SENT sid="198" pm="."><plain>All raw data files acquired were searched against the UniProt human database version 2014.01 (with 88,479 sequence entries) with MaxQuant proteomics computational platform version 1.3.0.5 and using Andromeda search engine55. </plain></SENT>
<SENT sid="199" pm="."><plain>In SILAC experiments light and heavy labels were set as Arg0/Lys0 and Arg6/Lys4. </plain></SENT>
<SENT sid="200" pm="."><plain>Precursor and fragment mass tolerances were set to 7 and 20 ppm, respectively. </plain></SENT>
<SENT sid="201" pm="."><plain>Enzyme specificity was set to trypsin, allowing for cleavage N-terminal to proline and between aspartic acid and proline with a maximum of 2 missed cleavages. </plain></SENT>
<SENT sid="202" pm="."><plain>Carbamidomethylation of cysteine (C) was set as fixed modification whereas oxidation of methionine (M), protein N-terminal acetylation, deamidation of asparagine and glutamine (NQ) and phosphorylation of serine/threonine/tyrosine (STY) were selected as variable modifications for database searching. </plain></SENT>
<SENT sid="203" pm="."><plain>For peptide and protein identification a minimal peptide length of 7 amino acids was required and the false discovery rate was set at 0.01. </plain></SENT>
<SENT sid="204" pm="."><plain>Additionally, for protein identification we demanded at least two peptides, of which at least one was unique to the protein group. </plain></SENT>
<SENT sid="205" pm="."><plain>Both razor and unique peptides, except STY phosphorylated peptides were considered for protein quantification. </plain></SENT>
<SENT sid="206" pm="."><plain>For the analysis of phosphopeptides, 1% FDR, a minimum localization probability of 0.75 and a score difference of at least 5 was used56. </plain></SENT>
<SENT sid="207" pm="."><plain>Proteins with ratio IL-2/Ctr &gt; 1.5; Significance B &lt; 0.0001 were regarded as significantly changing in the immunoprecipitated complexes following IL-2 treatment. </plain></SENT>
<SENT sid="208" pm="."><plain>In respect to phosphorylation changes, ratios IL-2/Ctr &gt; 2 were considered as significant. </plain></SENT>
</text></p><p><text><SENT sid="209" pm="."><plain>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium57 via PRIDE partner repository with the dataset identifier PXD003286. </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="210" pm="."><plain>Bioinformatic analysis </plain></SENT>
</text></title><p><text><SENT sid="211" pm="."><plain>Perseus statistical software was employed for the calculation of the statistical significance B, a p-value that depends on protein intensities and ratios. </plain></SENT>
<SENT sid="212" pm="."><plain>It was also used to perform the heat map and hierarchical clustering analysis in which protein groups were clustered according to their ratios and following next settings: row and column distance calculated using the Euclidean algorithm; row and column linkage – average58. </plain></SENT>
<SENT sid="213" pm="."><plain>Phosphosites not reported in the PhosphoSitePlus database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.phosphosite.org/homeAction.action">http://www.phosphosite.org/homeAction.action</ext-link>) were considered as novel. </plain></SENT>
<SENT sid="214" pm="."><plain>MS/MS spectra of the phosphorylated peptides bearing novel phosphosites of Gab2 were validated and annotated using MaxQuant viewer expert system59. </plain></SENT>
<SENT sid="215" pm="."><plain>Protein sequence alignment was performed by SIM (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://web.expasy.org/sim/">http://web.expasy.org/sim/</ext-link>) available in ExPASy Bioinformatics Resource Portal. </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="216" pm="."><plain>Western blot </plain></SENT>
</text></title><p><text><SENT sid="217" pm="."><plain>Eluted immune complexes were resolved in precast gradient NuPAGE 4–12% Bis-Tris gels (Invitrogen) and transferred onto nitrocellulose membranes (Bio-Rad). </plain></SENT>
<SENT sid="218" pm="."><plain>Membranes were blocked with 2% BSA and incubated overnight at 4 °C with primary antibodies, including; Gab2 (sc-9313), SHP2 (sc-7844) and 14-3-3 (sc-25276) from SantaCruz Biotechnology, ARID3A (A300-228 A) and ARID3B (A302-564 A) from Methyl Lab, GRB2 (610111, Transduction Lab), PI3 kinase p85 (#4257, Cell Signaling) and DLAT (ab126224, Abcam). </plain></SENT>
<SENT sid="219" pm="."><plain>Then, the membranes were repeatedly washed with TBST buffer (150 mM NaCl, 10 mM Tris, pH 8.0 and 0.1% Tween 20) and incubated with HRP-conjugated anti-rabbit (NA934, GE Healthcare), anti-mouse (NA931, GE Healthcare) or anti-goat (ref) secondary antibodies for 1 h at room temperature. </plain></SENT>
<SENT sid="220" pm="."><plain>Finally, the membranes were washed and processed with ECL solution (PRN2106, GE Healthcare) for detection scanning on a Kodak Image Station 1000. </plain></SENT>
<SENT sid="221" pm="."><plain>The intensity of the bands was quantified using ImageJ software (National Institutes of health, Bethesda, MD, USA). </plain></SENT>
</text></p></sec><sec disp-level="2"><title><text><SENT sid="222" pm="."><plain>RNA isolation and real-time qPCR for gene expression analyses </plain></SENT>
</text></title><p><text><SENT sid="223" pm="."><plain>Total RNA was extracted from cells using TRIzol reagent (Invitrogen) following manufacturer’s instructions. </plain></SENT>
<SENT sid="224" pm="."><plain>1 μg of RNA was then reverse transcribed into cDNA by incubating with a reaction mixture containing 0.25 μg of random hexamers and 1 mM dNTP mix for 5 min at 65 °C followed by 1 h incubation at 37 °C with 1st Stand buffer (Invitrogen), 1 mM DTT and 12 U of M-MLV reverse transcriptase (Promega). </plain></SENT>
<SENT sid="225" pm="."><plain>cDNA was amplified in the Strategene Mx2000P System using SYBR Green JumpStart Taq Ready Mix (Sigma-Aldrich) and quantified using Stratagene MxPro. </plain></SENT>
<SENT sid="226" pm="."><plain>Amplification of β-actin was used for normalization. </plain></SENT>
<SENT sid="227" pm="."><plain>Sequences of PCR primers are listed in Supplementary Table S1. </plain></SENT>
</text></p></sec></sec></SecTag><sec disp-level="1"><title><text><SENT sid="228" pm="."><plain>Additional Information </plain></SENT>
</text></title><p><text><SENT sid="229" pm="."><plain>How to cite this article: Osinalde, N. et al. Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes. Sci. </plain></SENT>
<SENT sid="230" pm="."><plain>Rep. 6, 23530; doi: 10.1038/srep23530 (2016). </plain></SENT>
</text></p></sec><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="S1"><title><text><SENT sid="231" pm="."><plain>Supplementary Material </plain></SENT>
</text></title><supplementary-material id="d33e26" content-type="local-data"><caption><title><text><SENT sid="232" pm="."><plain>Supplementary Information </plain></SENT>
</text></title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-s1.pdf"/></supplementary-material><supplementary-material id="d33e29" content-type="local-data"><caption><title><text><SENT sid="233" pm="."><plain>Supplementary Datset 1 </plain></SENT>
</text></title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-s2.xls"/></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="234" pm="."><plain>This project has been funded by a grant from the Novo Nordisk Foundation and the Lundbeck Foundation. </plain></SENT>
<SENT sid="235" pm="."><plain>N.O. is supported by the Lundbeck Foundation. </plain></SENT>
<SENT sid="236" pm="."><plain>I.K. is supported by grants from the Danish Natural Science Research Council and the Danish Medical Research Council. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><ref id="b1"><text><SENT sid="237" pm="."><plain>BoymanO., ChoJ. </plain></SENT>
<SENT sid="238" pm="."><plain>H. &amp; SprentJ. The role of interleukin-2 in memory CD8 cell differentiation. Adv Exp Med Biol 684, 28–41 (2010).20795538 </plain></SENT>
</text></ref><ref id="b2"><text><SENT sid="239" pm="."><plain>KamimuraD. &amp; BevanM. </plain></SENT>
<SENT sid="240" pm="."><plain>J. Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J Exp Med 204, 1803–1812, doi: 10.1084/jem.20070543 (2007).17664293 </plain></SENT>
</text></ref><ref id="b3"><text><SENT sid="241" pm="."><plain>LiaoW., LinJ. </plain></SENT>
<SENT sid="242" pm="."><plain>X., WangL., LiP. &amp; LeonardW. </plain></SENT>
<SENT sid="243" pm="."><plain>J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol 12, 551–559, doi: 10.1038/ni.2030 (2011).21516110 </plain></SENT>
</text></ref><ref id="b4"><text><SENT sid="244" pm="."><plain>WilliamsM. </plain></SENT>
<SENT sid="245" pm="."><plain>A., TyznikA. </plain></SENT>
<SENT sid="246" pm="."><plain>J. &amp; BevanM. </plain></SENT>
<SENT sid="247" pm="."><plain>J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441, 890–893, doi: 10.1038/nature04790 (2006).16778891 </plain></SENT>
</text></ref><ref id="b5"><text><SENT sid="248" pm="."><plain>RestifoN. </plain></SENT>
<SENT sid="249" pm="."><plain>P., DudleyM. </plain></SENT>
<SENT sid="250" pm="."><plain>E. &amp; RosenbergS. </plain></SENT>
<SENT sid="251" pm="."><plain>A. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12, 269–281, doi: 10.1038/nri3191 (2012).22437939 </plain></SENT>
</text></ref><ref id="b6"><text><SENT sid="252" pm="."><plain>RosenbergS. </plain></SENT>
<SENT sid="253" pm="."><plain>A. IL-2: the first effective immunotherapy for human cancer. J Immunol 192, 5451–5458, doi: 10.4049/jimmunol.1490019 (2014).24907378 </plain></SENT>
</text></ref><ref id="b7"><text><SENT sid="254" pm="."><plain>DybkaerK. et al. Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways. Bmc Genomics 8, doi: Artn23010.1186/1471-2164-8-230 (2007). </plain></SENT>
</text></ref><ref id="b8"><text><SENT sid="255" pm="."><plain>FriedmanM. </plain></SENT>
<SENT sid="256" pm="."><plain>C., MigoneT. </plain></SENT>
<SENT sid="257" pm="."><plain>S., RussellS. </plain></SENT>
<SENT sid="258" pm="."><plain>M. &amp; LeonardW. </plain></SENT>
<SENT sid="259" pm="."><plain>J. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA 93, 2077–2082, doi: 10.1073/pnas.93.5.2077 (1996).8700888 </plain></SENT>
</text></ref><ref id="b9"><text><SENT sid="260" pm="."><plain>NelsonB. </plain></SENT>
<SENT sid="261" pm="."><plain>H., LordJ. </plain></SENT>
<SENT sid="262" pm="."><plain>D. &amp; GreenbergP. </plain></SENT>
<SENT sid="263" pm="."><plain>D. A membrane-proximal region of the interleukin-2 receptor gamma(c) chain sufficient for Jak kinase activation and induction of proliferation in T cells. Mol Cell Biol 16, 309–317 (1996).8524310 </plain></SENT>
</text></ref><ref id="b10"><text><SENT sid="264" pm="."><plain>UsachevaA. et al. Contribution of the Box 1 and Box 2 motifs of cytokine receptors to Jak1 association and activation. J Biol Chem 277, 48220–48226, doi: 10.1074/jbc.M205757200 (2002).12374810 </plain></SENT>
</text></ref><ref id="b11"><text><SENT sid="265" pm="."><plain>OkutaniY. et al. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene 20, 6643–6650, doi: 10.1038/sj.onc.1204807 (2001).11641791 </plain></SENT>
</text></ref><ref id="b12"><text><SENT sid="266" pm="."><plain>ZhouY. </plain></SENT>
<SENT sid="267" pm="."><plain>J. et al. Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity. Proc Natl Acad Sci USA 94, 13850–13855 (1997).9391116 </plain></SENT>
</text></ref><ref id="b13"><text><SENT sid="268" pm="."><plain>ShawA. </plain></SENT>
<SENT sid="269" pm="."><plain>S. &amp; Filbert, E. </plain></SENT>
<SENT sid="270" pm="."><plain>L. </plain></SENT>
<SENT sid="271" pm="."><plain>Scaffold proteins and immune-cell signalling. Nat Rev Immunol 9, 47–56, doi: 10.1038/nri2473 (2009).19104498 </plain></SENT>
</text></ref><ref id="b14"><text><SENT sid="272" pm="."><plain>HalbachS. et al. Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Commun Signal 11, 30, doi: 10.1186/1478-811X-11-30 (2013).23607741 </plain></SENT>
</text></ref><ref id="b15"><text><SENT sid="273" pm="."><plain>NishidaK. et al. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood 93, 1809–1816 (1999).10068651 </plain></SENT>
</text></ref><ref id="b16"><text><SENT sid="274" pm="."><plain>WohrleF. </plain></SENT>
<SENT sid="275" pm="."><plain>U., DalyR. </plain></SENT>
<SENT sid="276" pm="."><plain>J. &amp; BrummerT. Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 7, 22, doi: 10.1186/1478-811X-7-22 (2009).19737390 </plain></SENT>
</text></ref><ref id="b17"><text><SENT sid="277" pm="."><plain>ArnaudM., CrouinC., DeonC., LoyauxD. &amp; BertoglioJ. Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation. J Immunol 173, 3962–3971 (2004).15356145 </plain></SENT>
</text></ref><ref id="b18"><text><SENT sid="278" pm="."><plain>ArnejaA., JohnsonH., GabrovsekL., LauffenburgerD. </plain></SENT>
<SENT sid="279" pm="."><plain>A. &amp; WhiteF. </plain></SENT>
<SENT sid="280" pm="."><plain>M. Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration. J Immunol 192, 123–135, doi: 10.4049/jimmunol.1302291 (2014).24298013 </plain></SENT>
</text></ref><ref id="b19"><text><SENT sid="281" pm="."><plain>GadinaM., SudarshanC. &amp; O’SheaJ. </plain></SENT>
<SENT sid="282" pm="."><plain>J. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3′-kinase, and Grb2. J Immunol 162, 2081–2086 (1999).9973481 </plain></SENT>
</text></ref><ref id="b20"><text><SENT sid="283" pm="."><plain>OsinaldeN. et al. Interleukin-2 signaling pathway analysis by quantitative phosphoproteomics. J Proteomics 75, 177–191, doi: 10.1016/j.jprot.2011.06.007 (2011).21722762 </plain></SENT>
</text></ref><ref id="b21"><text><SENT sid="284" pm="."><plain>OsinaldeN. et al. Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics. Proteomics 15, 520–531, doi: 10.1002/pmic.201400194 (2015).25142963 </plain></SENT>
</text></ref><ref id="b22"><text><SENT sid="285" pm="."><plain>LiuY. &amp; RohrschneiderL. </plain></SENT>
<SENT sid="286" pm="."><plain>R. The gift of Gab. FEBS Lett 515, 1–7 (2002).11943184 </plain></SENT>
</text></ref><ref id="b23"><text><SENT sid="287" pm="."><plain>AdamsS. </plain></SENT>
<SENT sid="288" pm="."><plain>J., AydinI. </plain></SENT>
<SENT sid="289" pm="."><plain>T. &amp; CelebiJ. </plain></SENT>
<SENT sid="290" pm="."><plain>T. GAB2–a scaffolding protein in cancer. Mol Cancer Res 10, 1265–1270, doi: 10.1158/1541-7786.MCR-12-0352 (2012).22871571 </plain></SENT>
</text></ref><ref id="b24"><text><SENT sid="291" pm="."><plain>BrummerT. et al. Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein. J Biol Chem 281, 626–637, doi: 10.1074/jbc.M509567200 (2006).16253990 </plain></SENT>
</text></ref><ref id="b25"><text><SENT sid="292" pm="."><plain>DalyR. </plain></SENT>
<SENT sid="293" pm="."><plain>J. et al. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 21, 5175–5181, doi: 10.1038/sj.onc.1205522 (2002).12140767 </plain></SENT>
</text></ref><ref id="b26"><text><SENT sid="294" pm="."><plain>LynchD. </plain></SENT>
<SENT sid="295" pm="."><plain>K. &amp; DalyR. </plain></SENT>
<SENT sid="296" pm="."><plain>J. PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J 21, 72–82 (2002).11782427 </plain></SENT>
</text></ref><ref id="b27"><text><SENT sid="297" pm="."><plain>BrummerT. et al. Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. EMBO J 27, 2305–2316 (2008).19172738 </plain></SENT>
</text></ref><ref id="b28"><text><SENT sid="298" pm="."><plain>Ortiz-PadillaC. et al. Functional characterization of cancer-associated Gab1 mutations. Oncogene 32, 2696–2702, doi: 10.1038/onc.2012.271 (2013).22751113 </plain></SENT>
</text></ref><ref id="b29"><text><SENT sid="299" pm="."><plain>BlagoevB. et al. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 21, 315–318, doi: 10.1038/nbt790nbt790 (2003).12577067 </plain></SENT>
</text></ref><ref id="b30"><text><SENT sid="300" pm="."><plain>ChylekL. </plain></SENT>
<SENT sid="301" pm="."><plain>A. et al. Phosphorylation site dynamics of early T-cell receptor signaling. PLoS One 9, e104240, doi: 10.1371/journal.pone.0104240PONE-D-14-22902 (2014).25147952 </plain></SENT>
</text></ref><ref id="b31"><text><SENT sid="302" pm="."><plain>DengjelJ., KratchmarovaI. &amp; BlagoevB. Receptor tyrosine kinase signaling: a view from quantitative proteomics. Mol Biosyst 5, 1112–1121, doi: 10.1039/b909534a (2009).19756300 </plain></SENT>
</text></ref><ref id="b32"><text><SENT sid="303" pm="."><plain>DengjelJ., KratchmarovaI. &amp; BlagoevB. Mapping protein-protein interactions by quantitative proteomics. Methods Mol Biol 658, 267–278, doi: 10.1007/978-1-60761-780-8_16 (2010).20839110 </plain></SENT>
</text></ref><ref id="b33"><text><SENT sid="304" pm="."><plain>HeinM. </plain></SENT>
<SENT sid="305" pm="."><plain>Y. et al. A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 163, 712–723, doi: S0092-8674(15)01270-210.1016/j.cell.2015.09.053 (2015).26496610 </plain></SENT>
</text></ref><ref id="b34"><text><SENT sid="306" pm="."><plain>SeiffertM. et al. Gab3-deficient mice exhibit normal development and hematopoiesis and are immunocompetent. Mol Cell Biol 23, 2415–2424 (2003).12640125 </plain></SENT>
</text></ref><ref id="b35"><text><SENT sid="307" pm="."><plain>WadaT. et al. The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat Med 11, 394–399, doi: 10.1038/nm1203 (2005).15750601 </plain></SENT>
</text></ref><ref id="b36"><text><SENT sid="308" pm="."><plain>ZhangY. et al. Abnormal hematopoiesis in Gab2 mutant mice. Blood 110, 116–124, doi: 10.1182/blood-2006-11-060707 (2007).17374739 </plain></SENT>
</text></ref><ref id="b37"><text><SENT sid="309" pm="."><plain>Wilson-GradyJ. </plain></SENT>
<SENT sid="310" pm="."><plain>T., HaasW. &amp; GygiS. </plain></SENT>
<SENT sid="311" pm="."><plain>P. Quantitative comparison of the fasted and re-fed mouse liver phosphoproteomes using lower pH reductive dimethylation. Methods 61, 277–286, doi: 10.1016/j.ymeth.2013.03.031 (2013).23567750 </plain></SENT>
</text></ref><ref id="b38"><text><SENT sid="312" pm="."><plain>LewitzkyM. et al. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene 20, 1052–1062, doi: 10.1038/sj.onc.1204202 (2001).11314042 </plain></SENT>
</text></ref><ref id="b39"><text><SENT sid="313" pm="."><plain>ArnaudM. et al. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2. Biochem J 382, 545–556, doi: 10.1042/BJ20040103 (2004).15170389 </plain></SENT>
</text></ref><ref id="b40"><text><SENT sid="314" pm="."><plain>CrouinC., ArnaudM., GesbertF., CamonisJ. &amp; BertoglioJ. A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners. FEBS Lett 495, 148–153 (2001).11334882 </plain></SENT>
</text></ref><ref id="b41"><text><SENT sid="315" pm="."><plain>GesbertF., GuenziC. &amp; BertoglioJ. A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes. J Biol Chem 273, 18273–18281 (1998).9660791 </plain></SENT>
</text></ref><ref id="b42"><text><SENT sid="316" pm="."><plain>SilvaJ. </plain></SENT>
<SENT sid="317" pm="."><plain>C., GorensteinM. </plain></SENT>
<SENT sid="318" pm="."><plain>V., LiG. </plain></SENT>
<SENT sid="319" pm="."><plain>Z., VissersJ. </plain></SENT>
<SENT sid="320" pm="."><plain>P. &amp; GeromanosS. </plain></SENT>
<SENT sid="321" pm="."><plain>J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 5, 144–156, doi: 10.1074/mcp.M500230-MCP200 (2006).16219938 </plain></SENT>
</text></ref><ref id="b43"><text><SENT sid="322" pm="."><plain>JohnstonJ. </plain></SENT>
<SENT sid="323" pm="."><plain>A. et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92, 8705–8709 (1995).7568001 </plain></SENT>
</text></ref><ref id="b44"><text><SENT sid="324" pm="."><plain>NakaokaY. &amp; KomuroI. Gab docking proteins in cardiovascular disease, cancer, and inflammation. Int J Inflam 2013, 141068, doi: 10.1155/2013/141068 (2013).23431498 </plain></SENT>
</text></ref><ref id="b45"><text><SENT sid="325" pm="."><plain>VaughanT. </plain></SENT>
<SENT sid="326" pm="."><plain>Y., VermaS. &amp; BuntingK. </plain></SENT>
<SENT sid="327" pm="."><plain>D. Grb2-associated binding (Gab) proteins in hematopoietic and immune cell biology. Am J Blood Res 1, 130–134 (2011).22163099 </plain></SENT>
</text></ref><ref id="b46"><text><SENT sid="328" pm="."><plain>Holgado-MadrugaM., EmletD. </plain></SENT>
<SENT sid="329" pm="."><plain>R., MoscatelloD. </plain></SENT>
<SENT sid="330" pm="."><plain>K., GodwinA. </plain></SENT>
<SENT sid="331" pm="."><plain>K. &amp; WongA. </plain></SENT>
<SENT sid="332" pm="."><plain>J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560–564, doi: 10.1038/379560a0 (1996).8596638 </plain></SENT>
</text></ref><ref id="b47"><text><SENT sid="333" pm="."><plain>ReebyeV. et al. A perspective on non-catalytic Src homology (SH) adaptor signalling proteins. Cell Signal 24, 388–392, doi: 10.1016/j.cellsig.2011.10.003 (2012).22024281 </plain></SENT>
</text></ref><ref id="b48"><text><SENT sid="334" pm="."><plain>NygaR. et al. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Biochem J 390, 359–366, doi: 10.1042/BJ20041523 (2005).15833084 </plain></SENT>
</text></ref><ref id="b49"><text><SENT sid="335" pm="."><plain>LiuY., JenkinsB., ShinJ. </plain></SENT>
<SENT sid="336" pm="."><plain>L. &amp; RohrschneiderL. </plain></SENT>
<SENT sid="337" pm="."><plain>R. Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase. Mol Cell Biol 21, 3047–3056, doi: 10.1128/MCB.21.9.3047-3056.2001 (2001).11287610 </plain></SENT>
</text></ref><ref id="b50"><text><SENT sid="338" pm="."><plain>ZhangX. et al. Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility. Mol Cell Biol 33, 1657–1670, doi: 10.1128/MCB.01353-12 (2013).23401857 </plain></SENT>
</text></ref><ref id="b51"><text><SENT sid="339" pm="."><plain>EulenfeldR. &amp; SchaperF. A new mechanism for the regulation of Gab1 recruitment to the plasma membrane. J Cell Sci 122, 55–64, doi: 10.1242/jcs.037226 (2009).19050043 </plain></SENT>
</text></ref><ref id="b52"><text><SENT sid="340" pm="."><plain>HoriT. et al. Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus. Blood 70, 1069–1072 (1987).3115332 </plain></SENT>
</text></ref><ref id="b53"><text><SENT sid="341" pm="."><plain>OsinaldeN., Sanchez-QuilesV., AkimovV., BlagoevB. &amp; KratchmarovaI. SILAC-based quantification of changes in protein tyrosine phosphorylation induced by Interleukin-2 (IL-2) and IL-15 in T-lymphocytes. Data Brief 5, 53–58, doi: 10.1016/j.dib.2015.08.007 (2015).26425665 </plain></SENT>
</text></ref><ref id="b54"><text><SENT sid="342" pm="."><plain>LarsenM. </plain></SENT>
<SENT sid="343" pm="."><plain>R., ThingholmT. </plain></SENT>
<SENT sid="344" pm="."><plain>E., JensenO. </plain></SENT>
<SENT sid="345" pm="."><plain>N., RoepstorffP. &amp; JorgensenT. </plain></SENT>
<SENT sid="346" pm="."><plain>J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 4, 873–886, doi: 10.1074/mcp.T500007-MCP200 (2005).15858219 </plain></SENT>
</text></ref><ref id="b55"><text><SENT sid="347" pm="."><plain>CoxJ. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10, 1794–1805, doi: 10.1021/pr101065j (2011).21254760 </plain></SENT>
</text></ref><ref id="b56"><text><SENT sid="348" pm="."><plain>OlsenJ. </plain></SENT>
<SENT sid="349" pm="."><plain>V. et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635–648, doi: 10.1016/j.cell.2006.09.026 (2006).17081983 </plain></SENT>
</text></ref><ref id="b57"><text><SENT sid="350" pm="."><plain>VizcainoJ. </plain></SENT>
<SENT sid="351" pm="."><plain>A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 32, 223–226, doi: 10.1038/nbt.2839 (2014).24727771 </plain></SENT>
</text></ref><ref id="b58"><text><SENT sid="352" pm="."><plain>CoxJ. &amp; MannM. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26, 1367–1372, doi: 10.1038/nbt.1511 (2008).19029910 </plain></SENT>
</text></ref><ref id="b59"><text><SENT sid="353" pm="."><plain>NeuhauserN., MichalskiA., CoxJ. &amp; MannM. Expert system for computer-assisted annotation of MS/MS spectra. Mol Cell Proteomics 11, 1500–1509, doi: 10.1074/mcp.M112.020271 (2012).22888147 </plain></SENT>
</text></ref></ref-list></SecTag><fn-group><fn><p><text><SENT sid="354" pm="."><plain>Author Contributions N.O., B.B. and I.K. designed the project; V.S. </plain></SENT>
<SENT sid="355" pm="."><plain>Analyzed the expression of Gab1–3 in different cell lines; N.O. carried out Gab2 interactome and Gab2 phosphorylation studies including sample preparation, LC-MS/MS, data analysis and bioinformatics analysis. </plain></SENT>
<SENT sid="356" pm="."><plain>N.O. wrote the manuscript; V.S., B.B. and I.K. critically revised the manuscript. </plain></SENT>
</text></p></fn></fn-group></back><floats-group><SecTag type="FIG"><fig id="f1"><label>Figure 1</label><caption><title>Expression of Gab family members.</title><p><text><SENT sid="357" pm="."><plain>(A) Gab1-3 gene expression was determined in HeLa and Kit225 cells using quantitative RT-PCR. </plain></SENT>
<SENT sid="358" pm="."><plain>(B) Gab1-2 protein levels were detected in HeLa and Kit225 T-cells by Western blot. </plain></SENT>
</text></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-f1"/></fig></SecTag><SecTag type="FIG"><fig id="f2"><label>Figure 2</label><caption><title>Experimental workflow followed to dissect IL-2-triggered regulation on Gab2.</title><p><text><SENT sid="359" pm="."><plain>(A) A schematic flow diagram depicting the steps for identification and quantification of Gab2 phosphopeptides as well as Gab2-interacting proteins. </plain></SENT>
<SENT sid="360" pm="."><plain>(B) Examples of SILAC MS spectra illustrating peptides that display different ratios. </plain></SENT>
<SENT sid="361" pm="."><plain>The left peptide shows no regulation by IL-2 (IL-2/Ctr ratio = 1) whereas the right peptide shows upregulation upon IL-2 stimulation (IL-2/Ctr ratio &gt; 1.5 for interacting proteins and IL-2/Ctr ratio &gt; 2 for phosphopeptides). </plain></SENT>
<SENT sid="362" pm="."><plain>Peptides derived from resting T-cells are marked in grey whereas the ones derived from IL-2-treated condition are marked in pink. </plain></SENT>
</text></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-f2"/></fig></SecTag><SecTag type="FIG"><fig id="f3"><label>Figure 3</label><caption><title>MS/MS spectra of novel Gab2 phosphopeptides identified.</title><p><text><SENT sid="363" pm="."><plain>Annotated MS/MS spectrum of a (A) triply phosphoryated Gab2 peptide (SpSPAELpSSpSSQHLLR) containing pS146, (B) doubly phosporylated Gab2 peptide (SpSPAELSpSSSSQHLLR) containing pS147 and (C) singly phosphorylated Gab2 peptide (SDSTNSEDNYVPoxMNPGpSSTLLAMER) bearing pS459. </plain></SENT>
<SENT sid="364" pm="."><plain>The b ions (in blue) and y ions (in red) identified are indicated both in the spectrum and in the peptide sequence * or ** denotes loss of one or two H3PO4 (Δm 97.9768) respectively, from the phosphorylated ion. </plain></SENT>
</text></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-f3"/></fig></SecTag><SecTag type="FIG"><fig id="f4"><label>Figure 4</label><caption><title>MS spectra of IL-2-induced Gab2 phosphopeptides not displaying a SILAC ratio.</title><p><text><SENT sid="365" pm="."><plain>MS spectra of (A) pS147-, (B) pS149- and (C) pS281-bearing phosphopeptides displaying no SILAC ratio. </plain></SENT>
<SENT sid="366" pm="."><plain>Whereas the light version of the phosphopeptide corresponding to resting T-cells (grey dot) is barely detectable, the heavy version of the same peptide (pink dot) is clearly distinguished indicating that upon cytokine stimulation Gab2 S147, S149 and S281 become phosphorylated. </plain></SENT>
</text></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-f4"/></fig></SecTag><SecTag type="FIG"><fig id="f5"><label>Figure 5</label><caption><title>Interactome of Gab2 in Kit225 T-cells.</title><p><text><SENT sid="367" pm="."><plain>(A) Venn diagram showing the overlap in proteins co-immunoprecipitating with Gab2 in the two biological replicates performed. </plain></SENT>
<SENT sid="368" pm="."><plain>(B) Correlation between IL-2/Ctr SILAC ratios obtained in the two replicates analyzed. </plain></SENT>
<SENT sid="369" pm="."><plain>(C) Combined IL-2/Ctr SILAC ratio corresponding to all the proteins quantified in the two biological replicas of each Gab2 immunoprecipitation is represented as a function of protein intensity in the MS. </plain></SENT>
<SENT sid="370" pm="."><plain>Dots coloured in red represent proteins that are consistently enriched (IL-2/Ctr &gt; 1.5; Significance B p-value &lt; 0.0001). </plain></SENT>
<SENT sid="371" pm="."><plain>(D) Heat map and hierarchical clustering dendrogram indicating the IL-2/Ctr SILAC ratio measured in each replicate of the proteins associating with Gab2 upon IL-2 stimulation. </plain></SENT>
</text></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-f5"/></fig></SecTag><SecTag type="FIG"><fig id="f6"><label>Figure 6</label><caption><title>IL-2-inducible Gab2-interacting proteins.</title><p><text><SENT sid="372" pm="."><plain>(A) Heat map and hierarchical clustering dendrogram indicating the SILAC IL-2/Ctr ratio displayed by the cytokine-inducible Gab2-binding protein in each replica. </plain></SENT>
<SENT sid="373" pm="."><plain>(B) Validation of selected well-known and novel Gab2-binding proteins by immunoblotting. </plain></SENT>
<SENT sid="374" pm="."><plain>(C) Relative binding abundance of the detected Gab2 interactors. *indicates described Gab2 interactors. </plain></SENT>
</text></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-f6"/></fig></SecTag><SecTag type="FIG"><fig id="f7"><label>Figure 7</label><caption><title>Gab2 phosphomap in IL-2-treated Kit225 T-lymphocytes.</title><p><text><SENT sid="375" pm="."><plain>Schematic representation of Gab2 structure indicating motifs, phosphosites and protein binding sites. </plain></SENT>
<SENT sid="376" pm="."><plain>IL-2-dependent and –independent phosphosites reported in this study are highlighted in red and black, respectively. *indicates that the phosphosite is not reported in PhosphoSitePlus database. </plain></SENT>
</text></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep23530-f7"/></fig></SecTag><SecTag type="TABLE"><table-wrap position="float" id="t1"><label>Table 1</label><caption><title>Gab2 serine/threonine phosphorylations.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th rowspan="3" align="left" valign="middle" charoff="50"><text><SENT sid="377" pm="."><plain>ModifiedGab2 site </plain></SENT>
</text></th><th rowspan="3" align="center" valign="middle" charoff="50"><text><SENT sid="378" pm="."><plain>Modified sequence </plain></SENT>
</text></th><th rowspan="3" align="center" valign="middle" charoff="50"><text><SENT sid="379" pm="."><plain>PEP </plain></SENT>
</text></th><th rowspan="3" align="center" valign="middle" charoff="50"><text><SENT sid="380" pm="."><plain>Score </plain></SENT>
</text></th><th rowspan="3" align="center" valign="middle" charoff="50"><text><SENT sid="381" pm="."><plain>Charge </plain></SENT>
</text></th><th rowspan="3" align="center" valign="middle" charoff="50"><text><SENT sid="382" pm="."><plain>m/z </plain></SENT>
</text></th><th colspan="3" align="left" valign="top" charoff="50"><text><SENT sid="383" pm="."><plain>Replica 1 </plain></SENT>
</text></th><th colspan="3" align="left" valign="top" charoff="50"><text><SENT sid="384" pm="."><plain>Replica 2 </plain></SENT>
</text></th><th rowspan="3" align="center" valign="middle" charoff="50"><text><SENT sid="385" pm="."><plain>Conserved in Gab3 </plain></SENT>
</text></th></tr><tr><th rowspan="2" align="center" valign="middle" charoff="50"><text><SENT sid="386" pm="."><plain>IL-2/Ctrratio </plain></SENT>
</text></th><th colspan="2" align="left" valign="top" charoff="50"><text><SENT sid="387" pm="."><plain>Peak Intensity </plain></SENT>
</text></th><th rowspan="2" align="center" valign="middle" charoff="50"><text><SENT sid="388" pm="."><plain>IL-2/Ctrratio </plain></SENT>
</text></th><th colspan="2" align="left" valign="top" charoff="50"><text><SENT sid="389" pm="."><plain>Peak Intensity </plain></SENT>
</text></th></tr><tr><th align="center" valign="top" charoff="50"><text><SENT sid="390" pm="."><plain>Ctr </plain></SENT>
</text></th><th align="center" valign="top" charoff="50"><text><SENT sid="391" pm="."><plain>IL-2 </plain></SENT>
</text></th><th align="center" valign="top" charoff="50"><text><SENT sid="392" pm="."><plain>Ctr </plain></SENT>
</text></th><th align="center" valign="top" charoff="50"><text><SENT sid="393" pm="."><plain>IL-2 </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50"><text><SENT sid="394" pm="."><plain>S133 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="395" pm="."><plain>NVSpSAGHGPR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="396" pm="."><plain>3.9E-03 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="397" pm="."><plain>123.92 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="398" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="399" pm="."><plain>531.23 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="400" pm="."><plain>27.0 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="401" pm="."><plain>3.1E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="402" pm="."><plain>8.6E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="403" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="404" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="405" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="406" pm="."><plain>S132* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="407" pm="."><plain>S141 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="408" pm="."><plain>SpSPAELSSSSQHLLR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="409" pm="."><plain>3.9E-98 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="410" pm="."><plain>253.73 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="411" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="412" pm="."><plain>839.89 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="413" pm="."><plain>9.0 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="414" pm="."><plain>1.1E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="415" pm="."><plain>2.5E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="416" pm="."><plain>3.5 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="417" pm="."><plain>1.5E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="418" pm="."><plain>2.5E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="419" pm="."><plain>T134* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="420" pm="."><plain>S146* </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="421" pm="."><plain>SpSPAELpSSpSSQHLLR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="422" pm="."><plain>1.8E-02 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="423" pm="."><plain>61.181 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="424" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="425" pm="."><plain>919.86 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="426" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="427" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="428" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="429" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="430" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="431" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="432" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="433" pm="."><plain>S147* </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="434" pm="."><plain>SpSPAELSpSSSQHLLR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="435" pm="."><plain>8.0E-48 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="436" pm="."><plain>183.56 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="437" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="438" pm="."><plain>879.88 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="439" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="440" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="441" pm="."><plain>2.7E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="442" pm="."><plain>31.1 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="443" pm="."><plain>4.2E+05 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="444" pm="."><plain>1.7E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="445" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="446" pm="."><plain>S148 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="447" pm="."><plain>pSSPAELSSpSSQHLLR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="448" pm="."><plain>3.9E-98 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="449" pm="."><plain>259.18 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="450" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="451" pm="."><plain>879.88 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="452" pm="."><plain>7.0 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="453" pm="."><plain>3.0E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="454" pm="."><plain>8.6E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="455" pm="."><plain>2.8 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="456" pm="."><plain>4.3E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="457" pm="."><plain>6.5E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="458" pm="."><plain>S141* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="459" pm="."><plain>S149 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="460" pm="."><plain>SpSPAELSSpSpSQHLLR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="461" pm="."><plain>1.0E-72 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="462" pm="."><plain>259.18 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="463" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="464" pm="."><plain>919.86 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="465" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="466" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="467" pm="."><plain>1.0E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="468" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="469" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="470" pm="."><plain>2.1E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="471" pm="."><plain>S142* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="472" pm="."><plain>S210 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="473" pm="."><plain>SApSFSQGTR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="474" pm="."><plain>9.6E-05 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="475" pm="."><plain>183.99 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="476" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="477" pm="."><plain>510.71 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="478" pm="."><plain>2.0 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="479" pm="."><plain>4.3E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="480" pm="."><plain>6.7E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="481" pm="."><plain>1.9 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="482" pm="."><plain>1.6E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="483" pm="."><plain>2.3E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="484" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="485" pm="."><plain>S223 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="486" pm="."><plain>ASFLoxMRpSDTAVQK </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="487" pm="."><plain>7.9E-21 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="488" pm="."><plain>184.37 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="489" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="490" pm="."><plain>775.36 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="491" pm="."><plain>8.1 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="492" pm="."><plain>6.2E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="493" pm="."><plain>1.2E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="494" pm="."><plain>2.2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="495" pm="."><plain>6.4E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="496" pm="."><plain>7.3E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="497" pm="."><plain>S209* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="498" pm="."><plain>S264 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="499" pm="."><plain>HNTEFRDpSTYDLPR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="500" pm="."><plain>5.9E-84 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="501" pm="."><plain>269.71 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="502" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="503" pm="."><plain>610.93 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="504" pm="."><plain>4.3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="505" pm="."><plain>4.5E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="506" pm="."><plain>1.7E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="507" pm="."><plain>9.9 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="508" pm="."><plain>7.9E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="509" pm="."><plain>3.1E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="510" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="511" pm="."><plain>T265 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="512" pm="."><plain>HNTEFRDSpTYDLPR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="513" pm="."><plain>2.9E-02 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="514" pm="."><plain>89.353 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="515" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="516" pm="."><plain>915.89 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="517" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="518" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="519" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="520" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="521" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="522" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="523" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="524" pm="."><plain>S281 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="525" pm="."><plain>GpSLTGSETDNEDVYTFK </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="526" pm="."><plain>5.8E-77 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="527" pm="."><plain>256.11 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="528" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="529" pm="."><plain>971.90 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="530" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="531" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="532" pm="."><plain>3.7E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="533" pm="."><plain>3.8 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="534" pm="."><plain>2.9E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="535" pm="."><plain>3.2E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="536" pm="."><plain>S242* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="537" pm="."><plain>S285 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="538" pm="."><plain>GSLTGpSETDNEDVYTFK </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="539" pm="."><plain>2.4E-52 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="540" pm="."><plain>298.22 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="541" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="542" pm="."><plain>971.90 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="543" pm="."><plain>3.4 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="544" pm="."><plain>5.9E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="545" pm="."><plain>4.4E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="546" pm="."><plain>3.9 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="547" pm="."><plain>4.5E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="548" pm="."><plain>2.8E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="549" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="550" pm="."><plain>T287 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="551" pm="."><plain>GSLTGSEpTDNEDVYTFK </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="552" pm="."><plain>6.3E-83 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="553" pm="."><plain>375.45 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="554" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="555" pm="."><plain>971.90 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="556" pm="."><plain>0.5 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="557" pm="."><plain>3.1E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="558" pm="."><plain>2.1E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="559" pm="."><plain>0.6 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="560" pm="."><plain>2.0E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="561" pm="."><plain>1.3E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="562" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="563" pm="."><plain>T319 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="564" pm="."><plain>EFGDLLVDNoxMDVPApTPLSAYQIPR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="565" pm="."><plain>6.7E-29 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="566" pm="."><plain>184 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="567" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="568" pm="."><plain>1379.15 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="569" pm="."><plain>7.9 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="570" pm="."><plain>9.9E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="571" pm="."><plain>3.2E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="572" pm="."><plain>18.8 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="573" pm="."><plain>1.9E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="574" pm="."><plain>9.2E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="575" pm="."><plain>S273* </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="576" pm="."><plain>S322 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="577" pm="."><plain>EFGDLLVDNoxMDVPATPLpSAYQIPR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="578" pm="."><plain>1.5E-20 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="579" pm="."><plain>170.27 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="580" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="581" pm="."><plain>919.77 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="582" pm="."><plain>9.1 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="583" pm="."><plain>3.2E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="584" pm="."><plain>8.5E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="585" pm="."><plain>10.3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="586" pm="."><plain>1.7E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="587" pm="."><plain>6.3E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="588" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="589" pm="."><plain>S368 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="590" pm="."><plain>WGpSPQQRPPISENSR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="591" pm="."><plain>2.3E-02 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="592" pm="."><plain>68.567 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="593" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="594" pm="."><plain>606.95 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="595" pm="."><plain>2.3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="596" pm="."><plain>4.3E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="597" pm="."><plain>2.7E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="598" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="599" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="600" pm="."><plain>– </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="601" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="602" pm="."><plain>T385 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="603" pm="."><plain>SVAApTIPRR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="604" pm="."><plain>1.2E-04 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="605" pm="."><plain>128.01 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="606" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="607" pm="."><plain>525.78 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="608" pm="."><plain>0.5 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="609" pm="."><plain>3.0E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="610" pm="."><plain>1.0E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="611" pm="."><plain>1.1 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="612" pm="."><plain>1.2E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="613" pm="."><plain>4.2E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="614" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="615" pm="."><plain>T391 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="616" pm="."><plain>RNpTLPAMDNSR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="617" pm="."><plain>1.2E-13 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="618" pm="."><plain>265.64 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="619" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="620" pm="."><plain>452.20 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="621" pm="."><plain>1.5 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="622" pm="."><plain>1.5E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="623" pm="."><plain>2.8E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="624" pm="."><plain>1.3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="625" pm="."><plain>3.8E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="626" pm="."><plain>4.0E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="627" pm="."><plain>S344 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="628" pm="."><plain>S404 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="629" pm="."><plain>LHRApSSCETYEYPQR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="630" pm="."><plain>3.8E-06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="631" pm="."><plain>141.6 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="632" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="633" pm="."><plain>659.62 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="634" pm="."><plain>13.8 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="635" pm="."><plain>7.9E+05 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="636" pm="."><plain>3.1E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="637" pm="."><plain>5.1 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="638" pm="."><plain>2.2E+05 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="639" pm="."><plain>1.9E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="640" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="641" pm="."><plain>S405 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="642" pm="."><plain>ASpSCETYEYPQR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="643" pm="."><plain>6.0E-07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="644" pm="."><plain>137.81 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="645" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="646" pm="."><plain>785.80 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="647" pm="."><plain>8.0 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="648" pm="."><plain>1.1E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="649" pm="."><plain>9.9E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="650" pm="."><plain>2.0 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="651" pm="."><plain>4.7E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="652" pm="."><plain>4.7E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="653" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="654" pm="."><plain>S422 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="655" pm="."><plain>pSAESoxMSDGVGSFLPGK </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="656" pm="."><plain>1.3E-44 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="657" pm="."><plain>210.75 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="658" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="659" pm="."><plain>832.85 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="660" pm="."><plain>8.3 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="661" pm="."><plain>4.4E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="662" pm="."><plain>3.4E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="663" pm="."><plain>5.0 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="664" pm="."><plain>3.4E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="665" pm="."><plain>6.3E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="666" pm="."><plain>S362 </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="667" pm="."><plain>S425 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="668" pm="."><plain>SAEpSMSDGVGSFLPGK </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="669" pm="."><plain>9.7E-45 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="670" pm="."><plain>221.79 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="671" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="672" pm="."><plain>824.85 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="673" pm="."><plain>5.9 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="674" pm="."><plain>4.4E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="675" pm="."><plain>1.8E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="676" pm="."><plain>7.1 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="677" pm="."><plain>1.6E+07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="678" pm="."><plain>1.1E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="679" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="680" pm="."><plain>S459* </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="681" pm="."><plain>SDSTNSEDNYVPoxMNPGpSSTLLAoxMER </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="682" pm="."><plain>2.7E-12 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="683" pm="."><plain>143.07 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="684" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="685" pm="."><plain>1414.08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="686" pm="."><plain>14.5 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="687" pm="."><plain>3.1E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="688" pm="."><plain>1.6E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="689" pm="."><plain>7.5 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="690" pm="."><plain>2.9E+06 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="691" pm="."><plain>1.1E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="692" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="693" pm="."><plain>S480 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="694" pm="."><plain>AGDNSQSVYIPoxMpSPGAHHFDSLGYPSTTLPVHR </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="695" pm="."><plain>1.3E-57 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="696" pm="."><plain>197 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="697" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="698" pm="."><plain>909.42 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="699" pm="."><plain>2.2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="700" pm="."><plain>5.7E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="701" pm="."><plain>1.7E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="702" pm="."><plain>2.2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="703" pm="."><plain>5.6E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="704" pm="."><plain>1.1E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="705" pm="."><plain>no </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" charoff="50"><text><SENT sid="706" pm="."><plain>S543 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="707" pm="."><plain>NNTVIDELPFKpSPITK </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="708" pm="."><plain>1.0E-210 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="709" pm="."><plain>350.82 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="710" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="711" pm="."><plain>948.48 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="712" pm="."><plain>8.7 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="713" pm="."><plain>5.0E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="714" pm="."><plain>5.1E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="715" pm="."><plain>4.9 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="716" pm="."><plain>4.8E+08 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="717" pm="."><plain>2.0E+09 </plain></SENT>
</text></td><td align="center" valign="top" charoff="50"><text><SENT sid="718" pm="."><plain>no </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="t1-fn1"><p>In bold are phosphorylations induced by IL-2 whereas IL-2-independent phosphorylations are in italics. *indicates that the phosphorylated site is not reported in PhosphoSitePlus database.</p></fn></table-wrap-foot></table-wrap></SecTag></floats-group></article>
